Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Sales (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Return on Sales data on record, last reported at 1.26% in Q4 2025.

  • For Q4 2025, Return on Sales fell 45.0% year-over-year to 1.26%; the TTM value through Dec 2025 reached 1.24%, down 24.0%, while the annual FY2025 figure was 1.24%, 24.0% down from the prior year.
  • Return on Sales reached 1.26% in Q4 2025 per MRVI's latest filing, down from 1.08% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.65% in Q3 2021 and bottomed at 2.5% in Q3 2024.
  • Average Return on Sales over 5 years is 0.31%, with a median of 0.2% recorded in 2023.
  • Peak YoY movement for Return on Sales: plummeted -227bps in 2024, then surged 142bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.56% in 2021, then dropped by -23bps to 0.43% in 2022, then tumbled by -447bps to 1.48% in 2023, then surged by 45bps to 0.81% in 2024, then tumbled by -55bps to 1.26% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 1.26% in Q4 2025, 1.08% in Q3 2025, and 1.47% in Q2 2025.